Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.02B |
| 2 |
Apple
AAPL
|
+$837M |
| 3 |
Amazon
AMZN
|
+$811M |
| 4 |
Kenvue
KVUE
|
+$761M |
| 5 |
Blackstone
BX
|
+$581M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$438M |
| 2 |
Texas Instruments
TXN
|
+$235M |
| 3 |
Pfizer
PFE
|
+$205M |
| 4 |
LSI
Life Storage, Inc.
LSI
|
+$202M |
| 5 |
BKI
Black Knight, Inc. Common Stock
BKI
|
+$145M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.7% |
| 2 | Healthcare | 13.07% |
| 3 | Financials | 12.46% |
| 4 | Consumer Discretionary | 10.84% |
| 5 | Industrials | 8.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3926
KULR Technology Group
KULR
$123M
| $229K | ﹤0.01% |
79,743
+6,521
| +9% | +$37.1K |
|
|
RGF
3927
DELISTED
The Real Good Food Company, Inc. Class A Common Stock
RGF
| $227K | ﹤0.01% |
5,657
+1,611
| +40% | +$78.9K |
|
|
BFX
3928
DELISTED
BowFlex Inc.
BFX
| $227K | ﹤0.01% |
267,294
-18,109
| -6% | -$17.9K |
|
|
PVLA
3929
Palvella Therapeutics
PVLA
$1.99B
| $227K | ﹤0.01% |
9,518
+1,225
| +15% | +$26.3K |
|
3930
Femasys
FEMY
$8.64M
| $226K | ﹤0.01% |
+3,795
| New | +$39.6K |
|
|
FATP
3931
DELISTED
Fat Projects Acquisition Corp Class A Ordinary Share
FATP
| $225K | ﹤0.01% |
20,151
| – | – |
|
3932
Rafael Holdings
RFL
$101M
| $225K | ﹤0.01% |
120,281
-2,485
| -2% | -$5.26K |
|
3933
NextCure
NXTC
$16.8M
| $225K | ﹤0.01% |
14,559
+1,427
| +11% | +$27.2K |
|
3934
Cenntro
CENN
$7.89M
| $225K | ﹤0.01% |
1,538
+617
| +67% | +$120K |
|
3935
SAB Biotherapeutics
SABS
$273M
| $225K | ﹤0.01% |
35,636
+5,583
| +19% | +$41K |
|
|
CRESY
3936
Cresud
CRESY
$795M
| $224K | ﹤0.01% |
34,112
| – | – |
|
3937
Research Solutions
RSSS
$73.6M
| $224K | ﹤0.01% |
90,602
+1,371
| +2% | +$3.04K |
|
|
XAGE
3938
DELISTED
Longevity Health Holdings, Inc. Common Stock
XAGE
| $224K | ﹤0.01% |
+2,071
| New | +$312K |
|
|
SEEL
3939
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
| $223K | ﹤0.01% |
316
+12
| +4% | +$51.5K |
|
|
ARCE
3940
DELISTED
Arco Platform Limited Class A Common Shares
ARCE
| $223K | ﹤0.01% |
16,151
| – | – |
|
3941
US Gold Corp
USAU
$214M
| $222K | ﹤0.01% |
71,518
+11,571
| +19% | +$45.7K |
|
|
SANW
3942
DELISTED
S&W Seed Co
SANW
| $222K | ﹤0.01% |
10,414
+1,176
| +13% | +$23.6K |
|
3943
PEDEVCO
PED
$144M
| $221K | ﹤0.01% |
10,951
-1,053
| -9% | -$20.1K |
|
3944
Crescent Capital BDC
CCAP
$403M
| $220K | ﹤0.01% |
12,883
| – | – |
|
3945
Siebert Financial
SIEB
$66.7M
| $219K | ﹤0.01% |
109,912
+17,400
| +19% | +$38.7K |
|
3946
Passage Bio
PASG
$14.4M
| $219K | ﹤0.01% |
16,610
+14
| +0.1% | +$230 |
|
3947
Xos
XOS
$28.8M
| $218K | ﹤0.01% |
21,118
+2,470
| +13% | +$26K |
|
3948
Celularity
CELU
$18.4M
| $217K | ﹤0.01% |
97,811
+10,098
| +12% | +$36.3K |
|
|
KORE
3949
DELISTED
KORE Group Holdings
KORE
| $217K | ﹤0.01% |
71,749
+23,434
| +49% | +$110K |
|
3950
TROOPS Inc
TROO
$208M
| $217K | ﹤0.01% |
52,367
| – | – |
|
Similar funds
Geode Capital Management's Q3 2023 Portfolio in Review
As of Q3 2023, Geode Capital Management held 4,905 positions worth $840B, down 1.3% from $851B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Geode Capital Management's Q3 2023 filing shows 147 new, 3,717 increased, 626 reduced and 142 closed positions. Its largest new stake was Kenvue: 32,873,626 shares worth $659M. The largest sale was Johnson & Johnson, an estimated $438M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 28% a quarter earlier, followed by Healthcare and Financials.
- Geode Capital Management's largest Q3 2023 buy was Kenvue: 32,873,626 shares worth $659M.
- Geode Capital Management added most to Microsoft in Q3 2023, an estimated $1.02B increase.
- Geode Capital Management's biggest Q3 2023 reduction was Johnson & Johnson, cutting an estimated $438M.
- Geode Capital Management fully exited Life Storage, Inc. in Q3 2023, selling an estimated $202M.
- Geode Capital Management's ten largest holdings make up 26% of its $840B portfolio in Q3 2023.
- Geode Capital Management opened 147 new positions and closed 142 in Q3 2023.
- Geode Capital Management's portfolio value fell 1.3% quarter-over-quarter to $840B.
Based on Geode Capital Management's 13F filing for Q3 2023, filed 13 Nov 2023.